非心电控CT扫描对慢阻肺合并冠心病患者冠脉血管钙化的诊断价值及影响因素分析

目的 探讨非心电控CT扫描对慢阻肺合并冠心病患者冠脉血管钙化的诊断价值以及冠脉血管钙化影响因素分析.方法 选取2017年1月至2018年12月我院心血管内科100例慢阻肺合并冠心病患者作为研究对象,根据患者是否发生冠脉血管钙化进行分组,其中发生冠脉血管钙化的52例患者作为钙化组,未出现冠脉血管钙化的48例患者作为对照组...

Analysis of Coronary Angiosteosis and its Influencing Factors in Patients with Chronic Obstructive Pulmonary Disease Combined with Coronary Heart Disease by Non-cardiac Electrical CT Scan

Objective To analyze coronary angiosteosis and its influencing factors in patients with chronic obstructive pulmonary disease combined with coronary heart disease by non-cardiac electrical computed tomography(CT).Methods From January 2017 to December 2018,100 patients with chronic obstructive pulmonary disease combined with coronary heart disease in our department of Internal Ca rdiovascular were enrolled as subjects.According to the presence of coronary angiosteosis,52 patients with coronary angiosteosis were used as the calcification group,and 48 patients without coronary angiosteosis were used as the control group.The inflammatory markers were compared between the two groups,and the influencing factors affecting co ronary angiosteosis were determined by logistic regression analysis.Results There was no significant difference in the expression levels of total cholesterol,triglyceride,high-density lipoprotein,and low-density lipoprotein between the two groups(P>0.05).The expression level of FEV1%in the calcification group was significantly lower than that in the non-calcification group(P<0.05).The duration of COPD in the calcification group was significantly longer than that in the non-calcification group(P<0.05).Logistic regression analysis showed that FEV1%was an independent risk factor for coronary vascular calcification(P<0.05).There was a negative correlation between FEV1%and coronary artery calcification score in the calcification group(P<0.05).The positive rate of CRP in the calcification group was significantly higher than that in the non-calcification group(P<0.05).Conclusion Non-cardiacelectrical CT scan can provide a reliable basis for diagnosing chronic obstructive pulmonary disease with coronary heart disease.Systemic inflammation will be enhanced in patients with chronic obstructive pulmonary disease com bined with coronary heart disease in the case of corona ry angiosteosis,in which the FEV1%is their protective factor.